Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 77,315	$ 73,228
Settlement Assets, Current	13,226	25,607
Short-term investments	31,357	4,443
Restricted Cash and Cash Equivalents, Current	7,883	35,051
Funds Held for Clients	4,500	4,966
Trade accounts receivable, less allowances of $20,634 and $21,696, respectively	129,768	153,565
Other current assets	63,880	67,074
Total current assets	327,929	363,934
Property and equipment, net	48,310	48,421
Operating Lease, Right-of-Use Asset	14,747	19,544
Goodwill	925,355	952,404
Intangibles, net	40,560	46,955
Indefinite-lived intangibles	42,055	42,055
Capitalized Software Development Costs for Software Sold to Customers	19,732	19,183
Deferred tax asset, net	66,605	69,227
Other assets	30,683	29,896
Total assets	1,515,976	1,591,619
Current liabilities:
Accounts payable and accrued liabilities	69,903	84,735
Settlement Liabilities, Current	4,394	12,196
Accrued payroll and related benefits	10,789	8,755
Bank Overdrafts	7,615	28,352
Funds Held for Clients, Liability	4,500	4,966
Short Term Debt, net	984	1,167
Current portion of long term debt and financing lease obligations, net of deferred financing costs of $920 and $575, respectively	23,620	22,091
Operating Lease, Liability, Current	4,739	5,955
Derivative Financial Instrument, Liabilities, Fair Value Disclosure, Current	6,122	8,621
Deferred Revenue, Current	29,013	28,712
Other current liabilities	36,308	29,335
Total current liabilities	197,987	234,885
Revolving line of credit	439,402	438,037
Long-term Debt and Capital Lease Obligations, net	243,074	254,467
Other liabilities	27,589	40,339
Derivative Financial Instrument, Liabilities, Fair Value Disclosure, Noncurrent	0	1,474
Deferred Revenue, Noncurrent	7,334	8,541
Operating Lease, Liability, Noncurrent	9,829	13,196
Deferred tax liability, net	1,235	1,235
Total liabilities	926,450	992,174
Commitments and Contingencies
Stockholders’ equity:
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at June 30, 2020 and December 31, 2019	0	0
Series Y Preferred Stock, Value, Issued	0	0
Common stock, $0.10 par value, 220,000,000 shares authorized, 30,507,903 issued and outstanding, at June 30, 2020, and 30,492,044 issued and outstanding at December 31, 2019	3,051	3,049
Additional paid-in capital	9,335	6,960
Retained Earnings (Accumulated Deficit)	660,767	618,503
Accumulated other comprehensive loss	(132,469)	(78,398)
Total stockholders’ equity	540,684	550,114
Stockholders' Equity Attributable to Noncontrolling Interest	48,842	49,331
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	589,526	599,445
Total liabilities and stockholders’ equity	$ 1,515,976	$ 1,591,619